Delusional disorder and eye tracking dysfunction: preliminary evidence of biological and clinical heterogeneity

Schizophrenia Research
A CampanaS Scarone

Abstract

This study used eye tracking movement tests to examine the relationships between frontal field functions and clinical features. Smooth pursuit and voluntary saccadic eye movements were recorded and analyzed in 34 delusional disorder (DD) patients and in 40 normal subjects. The DD group differed significantly from the group of normal subjects in some eye tracking performances. As reported in our previous study (Gambini et al., 1993), DD patients showed abnormalities of voluntary saccadic eye movements. In this study, we also found abnormal smooth pursuit eye movements, indicating a cerebral dysfunction similar to those detected in schizophrenic patients. Moreover, normal smooth pursuit eye movement performance in DD patients was related to remitted depressive mood and probably to benefit from antipsychotic medications, thus supporting the idea of the biological and clinical heterogeneity of DD.

References

Jan 1, 1992·European Archives of Psychiatry and Clinical Neuroscience·O Gambini, S Scarone
Jan 1, 1991·Schizophrenia Bulletin·M Flaum, N C Andreasen
Nov 1, 1983·Electroencephalography and Clinical Neurophysiology·J T HuttonR B Loewenson
Jan 1, 1994·European Archives of Psychiatry and Clinical Neuroscience·R SchlenkerP Werther
Jan 1, 1994·The Journal of Neuropsychiatry and Clinical Neurosciences·D MalaspinaH A Sackeim
Jan 1, 1993·Schizophrenia Bulletin·D L LevyN R Mendell
Jan 1, 1993·Psychopathology·C MarinoE Smeraldi
Sep 1, 1993·The American Journal of Psychiatry·O GambiniS Scarone
Jul 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·R G RossR Freedman

❮ Previous
Next ❯

Citations

Oct 2, 2012·Comprehensive Psychiatry·Enrique de PortugalJorge A Cervilla
Oct 11, 2008·Brain and Cognition·Gillian A O'Driscoll, Brandy L Callahan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here